Note, however, that depressive symptom scores increased slightly over the study period, and that presence of the APOE e4 allele did not predict death as a competing risk (HADS-Depression cut-off: p = 0.140; medication cut-off: p = 0.520). The gene discussed is APOE; the disease is depressive disorder.